The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Fluorine‐Containing Drugs Approved by the FDA in 2018
Abstract
Over the last two decades, fluorine substitution has become one of the essential structural traits in modern pharmaceuticals. Thus, about half of the most successful drugs (blockbuster drugs) contain fluorine atoms. In this review, we profile 17 fluorine‐containing drugs approved by the food and drug administration (FDA) in 2018. The newly approved pharmaceuticals feature several types of aromatic F and CF 3, as well as aliphatic (CF 2) substitution, offering advances in the treatment of various diseases, including cancer, HIV, malarial and smallpox infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Self-citationMulticomponent Reactions with Isocyanides
Dömling, A., & Ugi, I. (2000) · Angewandte Chemie · doi:10.1002/1521-3773(20000915)39:18<3168::aid-anie3168>3.0.co;2-u · Cited by 4,077
Zhou, Y., Wang, J., Gu, Z., Wang, S., Zhu, W., Aceña, J. L., Soloshonok, V. A., Izawa, K., & Liu, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00392 · Cited by 2,808
Self-citationFluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
Ilardi, E. A., Vitaku, E., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401375q · Cited by 1,604
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Smith, M. R., Saad, F., Chowdhury, S., Oudard, S., Hadaschik, B. A., Graff, J. N., Olmos, D., Mainwaring, P. N., Lee, J. Y., Uemura, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1715546 · Cited by 1,344
The Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
A Simple Catalytic Method for the Conversion of Aryl Bromides to Arylamines
Guram, A. S., Rennels, R. A., & Buchwald, S. L. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199513481 · Cited by 1,070
Solomon, B. J., Besse, B., Bauer, T. M., Felip, E., Soo, R. A., Camidge, D. R., Chiari, R., Bearz, A., Lin, C.-C., Gadgeel, S. M., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30649-1 · Cited by 791
Shaw, A. T., Felip, E., Bauer, T. M., Besse, B., Navarro, A., Postel-Vinay, S., Gainor, J. F., Johnson, M., Dietrich, J., James, L. P., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30680-0 · Cited by 659
Zhu, Y., Han, J., Wang, J., Shibata, N., Sodeoka, M., Soloshonok, V. A., Coelho, J. A. S., & Toste, F. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00778 · Cited by 640
Self-citationUnusual Amino Acids in Medicinal Chemistry
Blaskovich, M. A. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00319 · Cited by 635
19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications
Tirotta, I., Dichiarante, V., Pigliacelli, C., Cavallo, G., Terraneo, G., Bombelli, F. B., Metrangolo, P., & Resnati, G. (2015) · Chemical Reviews · doi:10.1021/cr500286d · Cited by 521
Recent advances in the trifluoromethylation methodology and new CF3-containing drugs
Zhu, W., Wang, J., Wang, S., Gu, Z., Aceña, J. L., Izawa, K., Liu, H., & Soloshonok, V. A. (2014) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2014.06.026 · Cited by 493
Self-citationChemistry with [18F]Fluoride Ion
Cai, L., Lu, S., & Pike, V. W. (2008) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200800114 · Cited by 469
Salwiczek, M., Nyakatura, E. K., Gerling, U. I. M., Ye, S., & Koksch, B. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15241f · Cited by 452
Popovici-Muller, J., Lemieux, R. M., Artin, E., Saunders, J. O., Salituro, F. G., Travins, J., Cianchetta, G., Cai, Z., Zhou, D., Cui, D., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00421 · Cited by 442
Gouverneur, V., & Müller, K. (2012) · Molecular Medicine and Medicinal Chemistry · doi:10.1142/p746 · Cited by 390
de Bono, J., Ramanathan, R. K., Mina, L., Chugh, R., Glaspy, J., Rafii, S., Kaye, S., Sachdev, J., Heymach, J., Smith, D. C., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1250 · Cited by 387
Noshi, T., Kitano, M., Taniguchi, K., Yamamoto, A., Omoto, S., Baba, K., Hashimoto, T., Ishida, K., Kushima, Y., Hattori, K., et al. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.10.008 · Cited by 381
Fluorinated amino acids in protein design and engineering
Yoder, N. C., & Kumar, K. (2002) · Chemical Society Reviews · doi:10.1039/b201097f · Cited by 317
Targeting ERK1/2 protein-serine/threonine kinases in human cancers
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.039 · Cited by 308
A Convergent Enantioselective Route to Structurally Diverse 6-Deoxytetracycline Antibiotics
Charest, M. G., Lerner, C. D., Brubaker, J. D., Siegel, D. R., & Myers, A. G. (2005) · Science · doi:10.1126/science.1109755 · Cited by 298
Ugi, I. (1962) · Angewandte Chemie · doi:10.1002/ange.19620740103 · Cited by 266
Larotrectinib: First Global Approval
Scott, L. J. (2019) · Drugs · doi:10.1007/s40265-018-1044-x · Cited by 237
Baloxavir: First Global Approval
Heo, Y. (2018) · Drugs · doi:10.1007/s40265-018-0899-1 · Cited by 211
Pine, P. R., Chang, B., Schoettler, N., Banquerigo, M. L., Wang, S., Lau, A., Zhao, F., Grossbard, E. B., Payan, D. G., & Brahn, E. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.543 · Cited by 208
Using 19F NMR to Probe Biological Interactions of Proteins and Peptides
Marsh, E. N. G., & Suzuki, Y. (2014) · ACS Chemical Biology · doi:10.1021/cb500111u · Cited by 203
Recent Advances in the Synthesis of Fluorinated Amino Acids
Qiu, X., & Qing, F. (2011) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201100032 · Cited by 196
Talazoparib: First Global Approval
Hoy, S. M. (2018) · Drugs · doi:10.1007/s40265-018-1026-z · Cited by 193
Fluorinated Proteins: From Design and Synthesis to Structure and Stability
Marsh, E. N. G. (2014) · Accounts of Chemical Research · doi:10.1021/ar500125m · Cited by 190
Donaldson, S. H., Pilewski, J. M., Griese, M., Cooke, J., Viswanathan, L., Tullis, E., Davies, J. C., Lekstrom-Himes, J. A., & Wang, L. T. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0717oc · Cited by 183
Wang, B., Chu, D., Feng, Y., Shen, Y., Aoyagi-Scharber, M., & Post, L. E. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01498 · Cited by 171
Shanks, G. D., Oloo, A. J., Aleman, G. M., Ohrt, C., Klotz, F. W., Braitman, D., Horton, J., & Brueckner, R. (2001) · Clinical Infectious Diseases · doi:10.1086/324081 · Cited by 168
Recent Advances in the Asymmetric Synthesis of α-(Trifluoromethyl)-Containing α-Amino Acids
Aceña, J., Soloshonok, V., & Sorochinsky, A. (2012) · Synthesis · doi:10.1055/s-0031-1289756 · Cited by 168
Self-citationFluorine in Peptide Design and Protein Engineering
Jäckel, C., & Koksch, B. (2005) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200500205 · Cited by 167
Dacomitinib: First Global Approval
Shirley, M. (2018) · Drugs · doi:10.1007/s40265-018-1028-x · Cited by 163
Ivosidenib: First Global Approval
Dhillon, S. (2018) · Drugs · doi:10.1007/s40265-018-0978-3 · Cited by 162
Sorochinsky, A. E., & Soloshonok, V. A. (2009) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2009.09.015 · Cited by 153
Self-citationLorlatinib: First Global Approval
Syed, Y. Y. (2019) · Drugs · doi:10.1007/s40265-018-1041-0 · Cited by 147
Malaria chemoprophylaxis with tafenoquine: a randomised study
Lell, B., Faucher, J., Missinou, M. A., Borrmann, S., Dangelmaier, O., Horton, J. D., & Kremsner, P. G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02352-7 · Cited by 143
The synthesis of peptides and proteins containing non-natural amino acids.
Hodgson, D. R. W., & Sanderson, J. M. (2004) · Chemical Society Reviews · doi:10.1039/b312953p · Cited by 142
DuBois, S. G., Laetsch, T. W., Federman, N. C., Turpin, B. K., Albert, C. M., Nagasubramanian, R., Anderson, M. E., Davis, J. L., Qamoos, H., Reynolds, M. E., et al. (2018) · Cancer · doi:10.1002/cncr.31701 · Cited by 138
Smith, M. R., Antonarakis, E. S., Ryan, C. J., Berry, W. R., Shore, N. D., Liu, G., Alumkal, J. J., Higano, C. S., Maneval, E. C., Bandekar, R. R., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.04.023 · Cited by 134
Xiao, X.-Y., Hunt, D. K., Zhou, J., Clark, R. B., Dunwoody, N., Fyfe, C., Grossman, T. H., O’Brien, W. J., Plamondon, L., Rönn, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201465w · Cited by 126
Aceña, J. L., Sorochinsky, A. E., Moriwaki, H., Sato, T., & Soloshonok, V. A. (2013) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2013.06.004 · Cited by 125
Self-citationThe self-disproportionation of enantiomers (SDE): a menace or an opportunity?
Han, J., Kitagawa, O., Wzorek, A., Klika, K. D., & Soloshonok, V. A. (2018) · Chemical Science · doi:10.1039/c7sc05138g · Cited by 121
Self-citationPractical Synthesis of Fluorine-Containing α- and β-Amino Acids: Recipes from Kiev, Ukraine
Kukhar, V. P., Sorochinsky, A. E., & Soloshonok, V. A. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.70 · Cited by 121
Self-citationChen, C., Wu, D., Guo, Z., Xie, Q., Reinhart, G. J., Madan, A., Wen, J., Chen, T., Huang, C. Q., Mi, C., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006454 · Cited by 120
Ziegler, D. S., Wong, M., Mayoh, C., Kumar, A., Tsoli, M., Mould, E. V. A., Tyrrell, V. J., Khuong-Quang, D.-A., Pinese, M., Gayevskiy, V., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0251-2 · Cited by 116
Basit, S., Ashraf, Z., Lee, K., & Latif, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.032 · Cited by 110
Han, J., Sorochinsky, A. E., Ono, T., & Soloshonok, V. A. (2011) · Current Organic Synthesis · doi:10.2174/157017911794697277 · Cited by 109
Self-citationCôté, B., Burch, J. D., Asante‐Appiah, E., Bayly, C., Bedard, L. L., Blouin, M., Campeau, L., Cauchon, E., Chan, M., Chefson, A., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.070 · Cited by 108
Soloshonok, V. A., Cai, C., Hruby, V. J., & Meervelt, L. V. (1999) · Tetrahedron · doi:10.1016/s0040-4020(99)00710-3 · Cited by 107
Self-citationDiscovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors
Singh, R., Masuda, E. S., & Payan, D. G. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201271b · Cited by 106
Elagolix: First global approval
Lamb, Y. N. (2018) · Drugs · doi:10.1007/s40265-018-0977-4 · Cited by 104
Rathkopf, D. E., Antonarakis, E. S., Shore, N. D., Tutrone, R. F., Jr., Alumkal, J. J., Ryan, C. J., Saleh, M. N., Hauke, R. J., Bandekar, R. R., Maneval, E. C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2509 · Cited by 94
Chen, X., Tsiang, M., Yu, F., Hung, M., Jones, G. S., Zeynalzadegan, A., Qi, X., JIN, H., Kim, C. U., Swaminathan, S., et al. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.054 · Cited by 90
Soloshonok, V. A., Sorochinsky, A. E., & Aceña, J. L. (2012) · Synthesis · doi:10.1055/s-0032-1316812 · Cited by 90
Self-citationKim, M. J., McDaid, J., McAdoo, S. P., Barratt, J., Molyneux, K., Masuda, E. S., Pusey, C. D., & Tam, F. W. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102603 · Cited by 80
A Practical, Enantioselective Synthetic Route to a Key Precursor to the Tetracycline Antibiotics
Brubaker, J. D., & Myers, A. G. (2007) · Organic Letters · doi:10.1021/ol071377d · Cited by 80
Koblar, A., Tavčar, G., & Ponikvar‐Svet, M. (2011) · Food Chemistry · doi:10.1016/j.foodchem.2011.07.037 · Cited by 78
Sato, T., Izawa, K., Aceña, J. L., Liu, H., & Soloshonok, V. A. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201600112 · Cited by 76
Self-citationApalutamide: First Global Approval
Al-Salama, Z. T. (2018) · Drugs · doi:10.1007/s40265-018-0900-z · Cited by 69
Smaill, J. B., Gonzales, A. J., Spicer, J. A., Lee, H., Reed, J. E., Sexton, K., Althaus, I. W., Zhu, T., Black, S. L., Blaser, A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00883 · Cited by 63
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
Bajpai, M., Chopra, P., Dastidar, S. G., & Ray, A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.5.641 · Cited by 62
Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
Ronn, M., Zhu, Z., Hogan, P. C., Zhang, W., Niu, J., Katz, C. E., Dunwoody, N., Gilicky, O., Deng, Y., Hunt, D. K., et al. (2013) · Organic Process Research & Development · doi:10.1021/op4000219 · Cited by 62
A Robust Kilo-Scale Synthesis of Doravirine
Campeau, L., Chen, Q., Gauvreau, D., Girardin, M., Belyk, K. M., Maligres, P. E., Zhou, G., Gu, C., Zhang, W., Tan, L., et al. (2016) · Organic Process Research & Development · doi:10.1021/acs.oprd.6b00163 · Cited by 62
Colombier, M.-A., & Molina, J. (2018) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000471 · Cited by 60
Elleraas, J., Ewanicki, J., Johnson, T. W., Sach, N. W., Collins, M. R., & Richardson, P. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509240 · Cited by 59
Soloshonok, V. A., Wzorek, A., & Klika, K. D. (2017) · Tetrahedron Asymmetry · doi:10.1016/j.tetasy.2017.08.020 · Cited by 54
Self-citationResearch Progress on PARP14 as a Drug Target
Qin, W. D., Wu, H., Cao, L.-Q., Li, H.-J., He, C., Zhao, D., Xing, L., Li, P.-Q., Jin, X., & Cao, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00172 · Cited by 52
Immunotoxicity assessment for the novel Spleen tyrosine kinase inhibitor R406
Zhu, Y., Herlaar, E., Masuda, E. S., Burleson, G. R., Nelson, A. J., Grossbard, E. B., & Clemens, G. R. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.027 · Cited by 51
Highly Efficient Synthesis of HIV NNRTI Doravirine
Gauthier, D. R., Sherry, B. D., Cao, Y., Journet, M., Humphrey, G. R., Itoh, T., Mangion, I. K., & Tschaen, D. M. (2015) · Organic Letters · doi:10.1021/ol503625z · Cited by 50
Fluoride in human health and nutrition
Štepec, D., & Ponikvar-Svet, M. (2019) · Acta Chimica Slovenica · doi:10.17344/acsi.2019.4932 · Cited by 49
Doravirine: First Global Approval
Deeks, E. D. (2018) · Drugs · doi:10.1007/s40265-018-0993-4 · Cited by 46
Ponikvar‐Svet, M., Stibilj, V., & Žemva, B. (2006) · Food Chemistry · doi:10.1016/j.foodchem.2006.07.032 · Cited by 45
Wang, S., Wang, Y., Wang, J., et al. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170522122424 · Cited by 30
Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
McKeage, K., & Lyseng-Williamson, K. A. (2018) · Drugs & Therapy Perspectives · doi:10.1007/s40267-018-0551-x · Cited by 29
Pang, X., Wang, Y., & Chen, Y. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.071 · Cited by 27
Investigational HIV integrase inhibitors in phase I and phase II clinical trials
Han, Y.-S., Mésplède, T., & Wainberg, M. A. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1378643 · Cited by 21
Pham, H. T., & Mésplède, T. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1560423 · Cited by 21
Zhang, W., Hogan, P. C., Chen, C.-L., Niu, J., Wang, Z., Lafrance, D., Gilicky, O., Dunwoody, N., & Ronn, M. (2015) · Organic Process Research & Development · doi:10.1021/acs.oprd.5b00274 · Cited by 20
Lorlatinib: a new-generation drug for ALK-positive NSCLC
Waqar, S. N., & Morgensztern, D. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30789-7 · Cited by 14
Argade, A. B., Bhamidipati, S., Li, H., Sylvain, C., Clough, J., Carroll, D., Keim, H., Braselmann, S., Taylor, V., Zhao, H., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.03.072 · Cited by 12
Elleraas, J., Ewanicki, J., Johnson, T. W., Sach, N. W., Collins, M. R., & Richardson, P. (2016) · Angewandte Chemie · doi:10.1002/ange.201509240 · Cited by 11
Drug updates and approvals: 2018 in review
Mospan, C. M., Mospan, G. A., Byland, E., Whitaker, W. B., Xiong, L., Dunlap, J., & Canupp, K. (2018) · The Nurse Practitioner · doi:10.1097/01.npr.0000547548.63764.6b · Cited by 10
Cited by
Contribution of Organofluorine Compounds to Pharmaceuticals
Inoue, M., Sumii, Y., & Shibata, N. (2020) · ACS Omega · doi:10.1021/acsomega.0c00830 · Cited by 1,944
Chemical Aspects of Human and Environmental Overload with Fluorine
Han, J., Kiss, L., Mei, H., Remete, A. M., Ponikvar-Svet, M., Sedgwick, D. M., Roman, R., Fustero, S., Moriwaki, H., & Soloshonok, V. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01263 · Cited by 537
Self-citationZhang, C., Yan, K., Fu, C., Peng, H., Hawker, C. J., & Whittaker, A. K. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00632 · Cited by 493
Next generation organofluorine containing blockbuster drugs
Han, J., Remete, A. M., Dobson, L. S., Kiss, L., Izawa, K., Moriwaki, H., Soloshonok, V. A., & O’Hagan, D. (2020) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2020.109639 · Cited by 313
Self-citationFluorinated Pyrazoles: From Synthesis to Applications
Mykhailiuk, P. K. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01015 · Cited by 297
Metadata
- Authors
- Mei, H., Han, J., Fustero, S., Medio‐Simon, M., Sedgwick, D. M., Santi, C., Ruzziconi, R., & Soloshonok, V. A.
- Venue
- Chemistry – A European Journal
- Publisher
- Wiley
- Published
- 2019-07-08
- Volume
- 25
- Issue
- 51
- Pages
- 11797-11819
- ISSN
- 0947-6539 (ISSN-L)
- 1521-3765
- OpenAlex
- W2945137288
- Cited by
- 454
- References
- 87
- FWCI
- 26.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.